home / stock / kalv / kalv quote
Last: | $10.78 |
---|---|
Change Percent: | -0.1% |
Open: | $10.5 |
Close: | $10.78 |
High: | $10.81 |
Low: | $10.26 |
Volume: | 241,417 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.78 | $10.5 | $10.78 | $10.81 | $10.26 | 241,417 | 04-26-2024 |
$10.49 | $10.12 | $10.49 | $10.52 | $10.105 | 363,775 | 04-25-2024 |
$10.35 | $11.18 | $10.35 | $11.18 | $10.32 | 423,679 | 04-24-2024 |
$11.21 | $11.43 | $11.21 | $11.7099 | $11.19 | 192,069 | 04-23-2024 |
$11.44 | $11.61 | $11.44 | $11.78 | $11.355 | 289,249 | 04-22-2024 |
$11.57 | $11.42 | $11.57 | $11.78 | $11.27 | 346,978 | 04-19-2024 |
$11.5 | $11.53 | $11.5 | $11.75 | $11.28 | 408,659 | 04-18-2024 |
$11.65 | $11.8 | $11.65 | $11.94 | $11.65 | 298,729 | 04-17-2024 |
$11.88 | $11.53 | $11.88 | $12.17 | $11.47 | 489,733 | 04-16-2024 |
$11.74 | $11.82 | $11.74 | $12.01 | $11.5 | 313,461 | 04-15-2024 |
$11.89 | $11.88 | $11.89 | $12.05 | $11.7 | 237,892 | 04-12-2024 |
$12.1 | $11.87 | $12.1 | $12.26 | $11.71 | 312,126 | 04-11-2024 |
$11.93 | $11.72 | $11.93 | $11.94 | $11.37 | 554,624 | 04-10-2024 |
$11.81 | $11.09 | $11.81 | $11.85 | $11.02 | 571,645 | 04-09-2024 |
$11.04 | $11.11 | $11.04 | $11.1967 | $10.82 | 210,204 | 04-08-2024 |
$11.09 | $11.13 | $11.09 | $11.375 | $10.97 | 184,360 | 04-05-2024 |
$11.21 | $11.3 | $11.21 | $11.42 | $10.945 | 500,284 | 04-04-2024 |
$11.26 | $11.01 | $11.26 | $11.34 | $10.81 | 221,914 | 04-03-2024 |
$11.04 | $11.15 | $11.04 | $11.48 | $10.915 | 1,473,247 | 04-02-2024 |
$11.4 | $11.77 | $11.4 | $11.79 | $11.03 | 817,261 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
KalVista Pharmaceuticals Inc. Company Name:
KALV Stock Symbol:
NASDAQ Market:
KalVista Pharmaceuticals Inc. Website:
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that William C. Fairey has been appointed to the Company’s Board of Directors, ef...
2024-04-12 19:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced its management will participate in a fireside chat at the 23 rd Annual Needham Virtu...